Ustekinumab Quantitation with Antibodies, Serum
Test Code
39986
80299, 83520
Clinical Significance
Ustekinumab Quantitation with Antibodies, Serum - Evaluation of loss of response to therapy.
Quantification of ustekinumab in human serum.
Trough level quantitation for evaluation of patients treated with ustekinumab.
Detection of antibodies to ustekinumab in human serum.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Collect immediately before next scheduled dose (trough specimen)
Methodology
Enzyme Linked Immunosorbent Assay (ELISA)
This test was developed and its performance characteristics have been determined by Mayo Clinic Laboratories. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test code is for New York patient testing. For non-New York patient testing, the recommended alternative test code is 18217.
This test code is for New York patient testing. For non-New York patient testing, the recommended alternative test code is 18217.
Preferred Specimen(s)
0.5 mL serum
Minimum Volume
0.35 mL
Collection Instructions
Collect immediately before next scheduled dose (trough specimen)
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: 21 days
- Frozen: 21 days
Reject Criteria
Gross hemolysis • Grossly lipemic • Heat-inactivated specimen
Setup Schedule
0.5 mL serum
0.35 mL
Collect immediately before next scheduled dose (trough specimen)
Transport tube
Refrigerated (cold packs)
Room temperature: Unacceptable
Refrigerated: 21 days
Frozen: 21 days
Refrigerated: 21 days
Frozen: 21 days
Gross hemolysis • Grossly lipemic • Heat-inactivated specimen